News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,642 Results
Type
Article (6314)
Company Profile (26)
Press Release (98302)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (30760)
Career Advice (199)
Deals (4755)
Drug Delivery (6)
Drug Development (8928)
Employer Resources (11)
FDA (2894)
Job Trends (2934)
News (49638)
Policy (5457)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (665)
Academic (1)
Accelerated approval (1)
Allergies (18)
Alliances (9964)
ALS (15)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (42)
Approvals (3009)
Artificial intelligence (76)
Autoimmune disease (11)
Automation (21)
Bankruptcy (26)
Best Places to Work (2268)
BIOSECURE Act (1)
Biosimilars (10)
Biotechnology (17)
Bladder cancer (39)
Brain cancer (7)
Breast cancer (128)
Cancer (835)
Cardiovascular disease (34)
Career advice (184)
Career pathing (1)
CAR-T (37)
CDC (2)
Celiac Disease (1)
Cell therapy (83)
Cervical cancer (10)
Clinical research (7278)
Collaboration (304)
Company closure (1)
Compensation (6)
Complete response letters (5)
COVID-19 (556)
CRISPR (14)
C-suite (92)
Cystic fibrosis (12)
Data (810)
Denatured (1)
Depression (5)
Diabetes (35)
Diagnostics (3324)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (48)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (17)
Earnings (9180)
Employer branding (3)
Employer resources (9)
Events (10626)
Executive appointments (137)
FDA (3280)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (2)
Funding (158)
Gene editing (22)
Generative AI (5)
Gene therapy (70)
GLP-1 (118)
Government (911)
Grass and pollen (3)
Guidances (46)
Healthcare (2255)
HIV (11)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (8)
Immuno-oncology (4)
Indications (19)
Infectious disease (610)
Inflammatory bowel disease (11)
Influenza (28)
Intellectual property (21)
Interviews (24)
IPO (1417)
IRA (1)
Job creations (774)
Job search strategy (174)
JPM (5)
Kidney cancer (1)
Labor market (4)
Layoffs (37)
Leadership (2)
Legal (1115)
Liver cancer (11)
Lung cancer (129)
Lymphoma (73)
Machine learning (7)
Management (3)
Manufacturing (135)
MASH (8)
Medical device (1393)
Medtech (1394)
Mergers & acquisitions (3461)
Metabolic disorders (70)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (29)
Neuropsychiatric disorders (1)
Neuroscience (297)
NextGen: Class of 2026 (791)
Non-profit (586)
Now hiring (14)
Obesity (27)
Opinion (18)
Ovarian cancer (18)
Pain (9)
Pancreatic cancer (24)
Parkinson's disease (20)
Partnered (7)
Patents (36)
Patient recruitment (24)
Peanut (10)
People (9497)
Pharmaceutical (6)
Phase 1 (2121)
Phase 2 (2767)
Phase 3 (2860)
Pipeline (654)
Policy (7)
Postmarket research (392)
Preclinical (1220)
Press Release (18)
Prostate cancer (38)
Psychedelics (2)
Radiopharmaceuticals (33)
Rare diseases (72)
Real estate (1982)
Recruiting (4)
Regulatory (4004)
Reports (7)
Research institute (643)
Resumes & cover letters (19)
Rett syndrome (2)
RSV (9)
Schizophrenia (2)
Series A (25)
Series B (10)
Sickle cell disease (9)
Spinal muscular atrophy (37)
Sponsored (7)
Startups (608)
State (1)
Stomach cancer (2)
Supply chain (19)
Tariffs (1)
The Weekly (1)
Vaccines (74)
Venture capital (1)
Weight loss (16)
Women's health (12)
Date
Last 7 days (54)
Last 30 days (212)
Last 365 days (3228)
2026 (283)
2025 (3324)
2024 (4373)
2023 (5218)
2022 (8519)
2021 (8913)
2020 (8710)
2019 (6069)
2018 (4717)
2017 (5134)
2016 (5242)
2015 (5784)
2014 (4661)
2013 (4139)
2012 (4391)
2011 (4464)
2010 (3986)
Location
Africa (126)
Alabama (11)
Alaska (1)
Arizona (45)
Arkansas (2)
Asia (6449)
Australia (1078)
California (1138)
Canada (349)
China (61)
Colorado (65)
Connecticut (47)
Delaware (49)
Europe (14116)
Florida (166)
Georgia (18)
Idaho (5)
Illinois (81)
India (8)
Indiana (72)
Iowa (2)
Japan (60)
Kansas (25)
Kentucky (7)
Louisiana (3)
Maine (27)
Maryland (150)
Massachusetts (774)
Michigan (87)
Minnesota (46)
Missouri (60)
Montana (9)
Nebraska (3)
Nevada (8)
New Hampshire (8)
New Jersey (516)
New Mexico (8)
New York (387)
North Carolina (208)
North Dakota (1)
Northern California (480)
Ohio (61)
Oklahoma (4)
Oregon (4)
Pennsylvania (172)
Rhode Island (11)
South America (176)
South Carolina (6)
Southern California (486)
Tennessee (28)
Texas (332)
United States (4699)
Utah (74)
Virginia (17)
Washington D.C. (6)
Washington State (113)
Wisconsin (20)
104,642 Results for "biolytical laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioLytical’s iStatis Syphilis Antibody Test Now Included in the Australian Register of Therapeutic Goods (ARTG)
October 13, 2025
·
4 min read
Press Releases
Health Canada Authorizes bioLytical’s iStatis Syphilis Test, Boosting Rapid Response to Rising Infections in Canada
July 23, 2025
·
5 min read
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
Biotech Bay
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
bioLytical Laboratories Inc. proudly announces its donation of 1,200 INSTI® HIV-1/2 Antibody Tests to KFF’s Greater Than AIDS campaign in support of National HIV Testing Day, June 27.
June 27, 2024
·
3 min read
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics and partner Coalition PLUS, a global NGO, announced that together, they have donated and distributed over 8,000 tests across 25 countries to help boost testing access worldwide.
November 22, 2023
·
4 min read
Press Releases
HIV and Syphilis Testing Just Got Faster: bioLytical Launches the 1-Minute INSTI® Multiplex HIV-1/2 Syphilis Antibody Test in Australia
March 19, 2025
·
5 min read
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it has received Health Canada authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test, allowing its immediate entry into the Canadian market.
March 27, 2023
·
6 min read
Press Releases
Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
January 28, 2026
·
3 min read
Press Releases
Charles River Laboratories Provides Business Updates
January 13, 2026
·
14 min read
bioLytical Laboratories Inc. receives WHO PQ for its iStatis COVID-19 Antigen Home Test
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced it has received its WHO PQ for its self-test, the iStatis COVID-19 Antigen Home Test, allowing its immediate entry into international markets.
October 18, 2022
·
4 min read
1 of 10,465
Next
